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6. Abstract 
The pyridine nucleotides NAD+ and NADP+ are essential coenzymes in numerous redox reac-
tions in all known organisms. Moreover, NAD+ and NADP+ are precursors of signal molecu-
les and substrates for covalent protein modifications in higher eukaryotes. When this study was
started no molecular data for the essential enzymes of NAD(P)+-synthesis, namely NMNAT
and NAD+-kinase were available. Therefore, molecular and cell biological analyses of
NAD(P)+ synthesis and its regulation had not been possible.  
In this study, for the first time a proteinchemical and cell biological examination of these two
proteins was conducted. The cDNA-sequence of the human NAD+-kinase was identified. The
protein was overexpressed in E. coli. The purified enzyme was used to generate antibodies that
enabled to the detection of the endogenous NAD+-kinase in human cells. The enzyme was
localised in the cytosol of transfected human cells. Human NAD+-kinase exibits a molecular
mass of approximately 50 kDa and forms a catalytically active homotetramer as demonstrated
by gelfiltration experiments. The enzyme is highly specific for its substrates ATP and NAD+.
No phosphorylation of different NAD+-analogues, among others NAAD+, was observed.
Therefore, the NAD+-kinase that was cloned during this study does nor appear to catalyse the
synthesis of the calcium releasing agent NAADP+.   
The mRNA encoding NAD+-kinase was detected in numerous human tissues except muscle.
Comparison of the cDNA sequence with genomic sequences and a southern blot analysis led
to the localisation of the NAD+-kinase gene on chromosom 1. The protein sequence of human
NAD+-kinase was compared with other NAD+-kinases that had been cloned from M. tubercu-
losis, E. coli and S. cervisiae. 38 conserved residues were identified. These residues are loca-
ted within a conserved protein domain which has been detected in approximately one hundred
so far uncharacterised proteins of different organisms. Among others, there was another human
protein containing this domain. This protein potentially represents a second human NAD+-
kinase. 
The human NMNAT was also overexpressed in E. coli. The purified protein was used to gene-
rate antibodies that permitted the visualisation of the enzyme exclusively in nuclei of human
cells. The primary structure of NMNAT indicated the presence of potential phosphorylation
sites. Indeed a phosphorylation of NMNAT in vitro and in vivo was detected. A phosphoryla-
tion site, Serin 136, was identified by mass spectrometric analyses and was confirmed by
mutagenesis studies. This Serin is located in close proximity to the NLS in a surface area of
the protein. Serin 136 is part of a consensus sequence that indicates modification by protein
kinase C. The influence of the two protein kinase C effectors PMA and BIM on this modifi-
cation in vitro and in vivo also supported a phosphorylation by this kinase. The function of the
modification is not known yet. No influence on the catalytic activity of NMNAT, the nuclear
localisation of the enzyme nor on the interaction with PARP was observed. 
These results  represent an important progress towards the understanding of NAD(P)+-synthe-
sis and the related energy and signaling processes. For the first time the key enzymes of
NAD(P)+-synthesis in eukaryotic cells have become accessible to investigations in vivo and in
vitro. 
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